On July 11, 2025, Kevin Feeley, Chief Financial Officer of GeneDx Holdings (WGS -2.26%), reported the sale of 5,278 shares of the company in multiple transactions, reducing his post-transaction holdings to 3,392 shares.Transaction summaryMetricValueShares Traded5,278Post-Transaction Shares3,392Key questionsHow does this transaction compare to the insider's recent activity?This sale of 5,278 shares is near the median trade size for Feeley, with a consistent pattern of selling in the last several quarters.Wha ...